VP Sales (Pharma)

TL;DR

VP Sales (Pharma): Leading strategic enterprise sales cycles for AI-driven patient engagement solutions with an accent on navigating complex multi-stakeholder pharmaceutical organizations. Focus on closing large-scale deals, driving revenue growth, and partnering with clinical and product teams to demonstrate measurable patient outcomes.

Location: Must be based in the United States with 20-40% travel expectations.

Company

hirify.global is a leading generative AI company in healthcare, building the world’s first safety-focused LLM platform for autonomous clinical conversations with patients.

What you will do

• Own and exceed revenue targets for the Pharma segment.
• Lead strategic enterprise sales cycles across 20 target pharma accounts from prospecting to close.
• Partner with Clinical, Product, and ML teams to tailor AI solutions for patient adherence and clinical trial recruitment.
• Develop ROI frameworks and business cases to demonstrate measurable patient outcomes.
• Drive forecast accuracy and pipeline hygiene through disciplined CRM management.
• Represent the company at key pharma conferences and executive briefings.

Requirements

• Must be based in the United States.
• Bachelor’s degree required; advanced degree preferred.
• 10+ years of enterprise sales experience, including 5+ years in pharma, life sciences, or healthcare technology.
• Proven track record of closing large ($1M+) enterprise deals.
• Experience selling consulting, SaaS, or AI/ML solutions.
• VP-level enterprise seller with a quota-carrying history of ~$3M+ ARR per year.

Nice to have

• Existing relationships with decision-makers at top pharma accounts.
• Experience with AI, digital health, or data-driven patient engagement platforms.
• Background in investment banking or management consulting for ROI modeling.
• Experience in high-growth startup or scale-up environments.

Culture & Benefits

• Opportunity to work with a team of physicians, hospital leaders, and AI pioneers from top institutions.
• Backed by world-leading healthcare and AI investors with significant funding.
• Focus on safety-first AI development to transform patient outcomes globally.
• Collaborative environment working alongside experts in healthcare and technology.